Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2021-07-06 Sale |
2021-07-08 5:23 pm |
NovoCure Ltd | NVCR | LEUNG GABRIEL Director |
1,000 | $183.54 | $183,540 | 76,204 (Direct) |
View |
| 2021-06-10 Sale |
2021-06-11 4:26 pm |
NovoCure Ltd | NVCR | Shah Pritesh Chief Commercial Officer |
23,540 | $215 | $5,061,100 | 77,732 (Direct) |
View |
| 2021-06-09 Sale |
2021-06-11 4:21 pm |
NovoCure Ltd | NVCR | HILLEMAN JERYL L Director |
1,270 | $210.01 | $266,713 | 4,443 (Direct) |
View |
| 2021-06-07 Sale |
2021-06-08 4:49 pm |
NovoCure Ltd | NVCR | LEUNG GABRIEL Director |
1,000 | $204.55 | $204,550 | 76,390 (Direct) |
View |
| 2021-05-27 Sale |
2021-05-28 4:36 pm |
NovoCure Ltd | NVCR | Benaim Ely Chief Medical Officer |
1,833 | $200 | $366,600 | 36,386 (Direct) |
View |
| 2021-05-12 Sale |
2021-05-14 4:07 pm |
NovoCure Ltd | NVCR | Benaim Ely Chief Medical Officer |
1,943 | $180.48 | $350,673 | 29,054 (Direct) |
View |
| 2021-05-10 Sale |
2021-05-12 4:15 pm |
NovoCure Ltd | NVCR | Benaim Ely Chief Medical Officer |
4,095 | $184.38 | $755,055 | 40,162 (Direct) |
View |
| 2021-05-10 Sale |
2021-05-12 4:13 pm |
NovoCure Ltd | NVCR | Weinberg Uri Chief Science Officer |
5,650 | $189.65 | $1,071,523 | 35,512 (Direct) |
View |
| 2021-05-05 Sale |
2021-05-06 4:17 pm |
NovoCure Ltd | NVCR | Shah Pritesh Chief Commercial Officer |
1,290 | $199.67 | $257,574 | 101,272 (Direct) |
View |
| 2021-05-05 Sale |
2021-05-06 4:15 pm |
NovoCure Ltd | NVCR | LEUNG GABRIEL Director |
1,000 | $199.67 | $199,670 | 77,390 (Direct) |
View |
| 2021-05-04 Sale |
2021-05-05 4:09 pm |
NovoCure Ltd | NVCR | Shah Pritesh Chief Commercial Officer |
1,043 | $200.86 | $209,493 | 102,562 (Direct) |
View |
| 2021-04-13 Sale |
2021-04-15 6:29 pm |
NovoCure Ltd | NVCR | DOYLE WILLIAM F Executive Chairman |
95,000 | $199.55 | $18,957,452 | 555,393 (Direct) |
View |
| 2021-04-13 Sale |
2021-04-15 6:01 pm |
NovoCure Ltd | NVCR | Danziger Asaf Chief Executive Officer |
97,973 | $196.34 | $19,236,323 | 8,184 (Direct) |
View |
| 2021-04-13 Sale |
2021-04-15 6:00 pm |
NovoCure Ltd | NVCR | LEUNG GABRIEL Director |
6,000 | $198.84 | $1,193,035 | 78,390 (Direct) |
View |
| 2021-04-13 Sale |
2021-04-15 5:59 pm |
NovoCure Ltd | NVCR | Benaim Ely Chief Medical Officer |
5,958 | $200 | $1,191,600 | 67,565 (Direct) |
View |
| 2021-03-23 Sale(A) |
2021-04-09 4:25 pm |
NovoCure Ltd | NVCR | Weinberg Uri Chief Science Officer |
2,835 | $140 | $396,900 | 33,471 (Direct) |
View |
| 2021-04-01 Sale |
2021-04-02 4:14 pm |
NovoCure Ltd | NVCR | DOYLE WILLIAM F Executive Chairman |
7,928 | $134.12 | $1,063,303 | 650,393 (Direct) |
View |
| 2021-03-23 Sale |
2021-03-25 4:40 pm |
NovoCure Ltd | NVCR | Weinberg Uri Chief Science Officer |
3,892 | $140 | $544,880 | 40,198 (Direct) |
View |
| 2021-03-05 Sale |
2021-03-09 4:17 pm |
NovoCure Ltd | NVCR | Shah Pritesh Chief Commercial Officer |
4,550 | $131.53 | $598,462 | 107,423 (Direct) |
View |
| 2021-03-05 Sale |
2021-03-09 4:16 pm |
NovoCure Ltd | NVCR | Benaim Ely Chief Medical Officer |
2,918 | $131.53 | $383,805 | 33,259 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2021-07-06 Option Award |
2021-07-08 5:36 pm |
N/A N/A |
NovoCure Ltd | NVCR | Leonard Frank X Chief Development Officer |
154 | $137.12 | 90,199 (Direct) |
View |
| 2021-07-06 Option Award |
2021-07-08 5:35 pm |
N/A N/A |
NovoCure Ltd | NVCR | Cordova Ashley Chief Financial Officer |
100 | $137.12 | 35,993 (Direct) |
View |
| 2021-07-06 Option Award |
2021-07-08 5:34 pm |
N/A N/A |
NovoCure Ltd | NVCR | GROENHUYSEN WILHELMUS CM Chief Operating Officer |
66 | $137.12 | 150,080 (Direct) |
View |
| 2021-07-06 Option Award |
2021-07-08 5:32 pm |
N/A N/A |
NovoCure Ltd | NVCR | Benaim Ely Chief Medical Officer |
90 | $137.12 | 29,144 (Direct) |
View |
| 2021-07-06 Option Award |
2021-07-08 5:31 pm |
N/A N/A |
NovoCure Ltd | NVCR | Danziger Asaf Chief Executive Officer |
118 | $137.12 | 8,302 (Direct) |
View |
| 2021-07-06 Option Award |
2021-07-08 5:29 pm |
N/A N/A |
NovoCure Ltd | NVCR | Shah Pritesh Chief Commercial Officer |
154 | $137.12 | 77,886 (Direct) |
View |
| 2021-07-06 Option Award |
2021-07-08 5:26 pm |
N/A N/A |
NovoCure Ltd | NVCR | Longsworth Todd Christopher General Counsel |
154 | $137.12 | 67,868 (Direct) |
View |
| 2021-07-06 Exercise |
2021-07-08 5:23 pm |
N/A N/A |
NovoCure Ltd | NVCR | LEUNG GABRIEL Director |
1,000 | $31.45 | 76,204 (Direct) |
View |
| 2021-07-06 Exercise |
2021-07-08 5:23 pm |
N/A 2028-05-30 |
NovoCure Ltd | NVCR | LEUNG GABRIEL Director |
1,000 | $0 | 76,204 (Direct) |
View |
| 2021-06-09 Option Award |
2021-06-11 4:24 pm |
N/A 2031-06-09 |
NovoCure Ltd | NVCR | McCoy Sherilyn S Director |
2,313 | $0 | 8,213 (Direct) |
View |
| 2021-06-09 Option Award |
2021-06-11 4:22 pm |
N/A 2031-06-09 |
NovoCure Ltd | NVCR | Madden Martin J. Director |
2,313 | $0 | 17,537 (Direct) |
View |
| 2021-06-09 Option Award |
2021-06-11 4:22 pm |
N/A 2031-06-09 |
NovoCure Ltd | NVCR | VERNON W ANTHONY Director |
2,313 | $0 | 163,443 (Direct) |
View |
| 2021-06-09 Option Award |
2021-06-11 4:21 pm |
N/A 2031-06-09 |
NovoCure Ltd | NVCR | HILLEMAN JERYL L Director |
2,313 | $0 | 4,443 (Direct) |
View |
| 2021-06-09 Option Award |
2021-06-11 4:19 pm |
N/A 2031-06-09 |
NovoCure Ltd | NVCR | Hung David Director |
2,313 | $0 | 8,213 (Direct) |
View |
| 2021-06-09 Option Award |
2021-06-11 4:18 pm |
N/A 2031-06-09 |
NovoCure Ltd | NVCR | LEUNG GABRIEL Director |
2,313 | $0 | 74,358 (Direct) |
View |
| 2021-06-07 Exercise |
2021-06-08 4:49 pm |
N/A N/A |
NovoCure Ltd | NVCR | LEUNG GABRIEL Director |
1,000 | $31.45 | 76,390 (Direct) |
View |
| 2021-06-07 Exercise |
2021-06-08 4:49 pm |
N/A 2028-05-30 |
NovoCure Ltd | NVCR | LEUNG GABRIEL Director |
1,000 | $0 | 76,390 (Direct) |
View |
| 2021-05-27 Exercise |
2021-05-28 4:36 pm |
N/A N/A |
NovoCure Ltd | NVCR | Benaim Ely Chief Medical Officer |
1,833 | $47.56 | 36,386 (Direct) |
View |
| 2021-05-27 Exercise |
2021-05-28 4:36 pm |
N/A 2029-05-07 |
NovoCure Ltd | NVCR | Benaim Ely Chief Medical Officer |
1,833 | $0 | 36,386 (Direct) |
View |
| 2021-05-10 Exercise |
2021-05-12 4:15 pm |
N/A N/A |
NovoCure Ltd | NVCR | Benaim Ely Chief Medical Officer |
1,833 | $47.56 | 40,162 (Direct) |
View |
| 2021-05-10 Exercise |
2021-05-12 4:15 pm |
N/A 2029-05-07 |
NovoCure Ltd | NVCR | Benaim Ely Chief Medical Officer |
1,833 | $0 | 40,162 (Direct) |
View |
| 2021-05-10 Exercise |
2021-05-12 4:13 pm |
N/A N/A |
NovoCure Ltd | NVCR | Weinberg Uri Chief Science Officer |
3,846 | $47.56 | 35,512 (Direct) |
View |
| 2021-05-10 Exercise |
2021-05-12 4:13 pm |
N/A 2029-05-07 |
NovoCure Ltd | NVCR | Weinberg Uri Chief Science Officer |
3,846 | $0 | 35,512 (Direct) |
View |
| 2021-05-05 Exercise |
2021-05-06 4:15 pm |
N/A N/A |
NovoCure Ltd | NVCR | LEUNG GABRIEL Director |
1,000 | $31.45 | 77,390 (Direct) |
View |
| 2021-05-05 Exercise |
2021-05-06 4:15 pm |
N/A 2028-05-30 |
NovoCure Ltd | NVCR | LEUNG GABRIEL Director |
1,000 | $0 | 77,390 (Direct) |
View |
| 2021-05-03 Exercise |
2021-05-05 4:09 pm |
N/A N/A |
NovoCure Ltd | NVCR | Shah Pritesh Chief Commercial Officer |
2,333 | $204.1 | 102,562 (Direct) |
View |
| 2021-05-03 Exercise |
2021-05-05 4:09 pm |
2021-05-01 N/A |
NovoCure Ltd | NVCR | Shah Pritesh Chief Commercial Officer |
2,333 | $0 | 102,562 (Direct) |
View |
| 2021-04-13 Exercise |
2021-04-15 6:00 pm |
N/A N/A |
NovoCure Ltd | NVCR | LEUNG GABRIEL Director |
6,000 | $31.45 | 78,390 (Direct) |
View |
| 2021-04-13 Exercise |
2021-04-15 6:00 pm |
N/A 2028-05-31 |
NovoCure Ltd | NVCR | LEUNG GABRIEL Director |
6,000 | $0 | 78,390 (Direct) |
View |
| 2021-04-13 Exercise |
2021-04-15 5:59 pm |
N/A N/A |
NovoCure Ltd | NVCR | Benaim Ely Chief Medical Officer |
3,474 | $69.37 | 67,565 (Direct) |
View |
| 2021-04-13 Exercise |
2021-04-15 5:59 pm |
N/A N/A |
NovoCure Ltd | NVCR | Benaim Ely Chief Medical Officer |
651 | $83.3 | 67,565 (Direct) |
View |
| 2021-04-13 Exercise |
2021-04-15 5:59 pm |
N/A N/A |
NovoCure Ltd | NVCR | Benaim Ely Chief Medical Officer |
1,833 | $47.56 | 67,565 (Direct) |
View |
| 2021-04-13 Exercise |
2021-04-15 5:59 pm |
N/A 2029-05-07 |
NovoCure Ltd | NVCR | Benaim Ely Chief Medical Officer |
5,958 | $0 | 67,565 (Direct) |
View |
| 2021-03-31 Exercise |
2021-04-02 4:14 pm |
N/A N/A |
NovoCure Ltd | NVCR | DOYLE WILLIAM F Executive Chairman |
9,259 | $125.25 | 650,393 (Direct) |
View |
| 2021-03-31 Exercise |
2021-04-02 4:14 pm |
2019-03-31 N/A |
NovoCure Ltd | NVCR | DOYLE WILLIAM F Executive Chairman |
9,259 | $0 | 650,393 (Direct) |
View |
| 2021-03-23 Exercise |
2021-03-25 4:40 pm |
N/A N/A |
NovoCure Ltd | NVCR | Weinberg Uri Chief Science Officer |
3,892 | $47.04 | 40,198 (Direct) |
View |
| 2021-03-23 Exercise |
2021-03-25 4:40 pm |
N/A 2029-03-21 |
NovoCure Ltd | NVCR | Weinberg Uri Chief Science Officer |
3,892 | $0 | 40,198 (Direct) |
View |
| 2021-03-05 Exercise |
2021-03-09 4:17 pm |
N/A N/A |
NovoCure Ltd | NVCR | Shah Pritesh Chief Commercial Officer |
13,987 | $7.15 | 107,423 (Direct) |
View |
| 2021-03-05 Exercise |
2021-03-09 4:17 pm |
N/A 2027-02-21 |
NovoCure Ltd | NVCR | Shah Pritesh Chief Commercial Officer |
13,987 | $0 | 107,423 (Direct) |
View |